当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析

太龙药业

(600222)

  

流通市值:29.53亿  总市值:30.30亿
流通股本:5.59亿   总股本:5.74亿

太龙药业(600222)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润0.45亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益162338.85万元,未分配利润23010.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产357685.49万元,负债195346.64万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入2,069,908,736.551,442,869,622.59993,909,739.6560,317,916.01
营业总成本2,035,858,489.191,474,043,456.351,036,057,414.64558,034,043.53
营业利润44,166,520.95-20,740,290.65-48,259,650.472,816,063.62
利润总额42,962,466.36-20,990,059.74-48,389,8512,812,468.66
净利润44,829,287.68-19,520,675.95-42,839,914.13,288,380.45
其他综合收益6,587,224.43-60,524,667.89-71,207,757.23-29,619,370.55
综合收益总额51,416,512.11-80,045,343.84-114,047,671.33-26,330,990.1
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计1,993,073,631.391,836,729,817.061,863,188,037.51,982,901,387.93
非流动资产合计1,583,781,293.821,502,593,248.141,532,179,064.261,589,611,259.02
资产总计3,576,854,925.213,339,323,065.23,395,367,101.763,572,512,646.95
流动负债合计1,650,148,331.721,721,354,115.431,798,669,217.091,907,172,501.96
非流动负债合计303,318,076.47125,997,639.94138,728,902.3368,749,799.18
负债合计1,953,466,408.191,847,351,755.371,937,398,119.421,975,922,301.14
归属于母公司股东权益合计1,578,493,578.61,450,960,475.161,418,871,940.831,553,379,373.18
股东权益合计1,623,388,517.021,491,971,309.831,457,968,982.341,596,590,345.81
负债和股东权益合计3,576,854,925.213,339,323,065.23,395,367,101.763,572,512,646.95
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计2,133,902,735.781,536,950,225.671,016,427,811.75495,801,337.2
经营活动现金流出小计2,090,165,160.381,589,639,948.691,104,429,635.75588,069,677.76
经营活动产生的现金流量净额43,737,575.4-52,689,723.02-88,001,824-92,268,340.56
投资活动现金流入小计590,525,959.93432,472,654.58150,061,195.9962,926,917.78
投资活动现金流出小计740,545,320.25469,043,933.74208,974,895.7382,565,727.97
投资活动产生的现金流量净额-150,019,360.32-36,571,279.16-58,913,699.74-19,638,810.19
筹资活动现金流入小计1,110,176,752.12521,502,225.75399,703,900.83159,719,213.09
筹资活动现金流出小计1,083,612,734.75540,648,987.23366,591,511.84110,733,733.62
筹资活动产生的现金流量净额26,564,017.37-19,146,761.4833,112,388.9948,985,479.47
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-79,717,767.55-108,407,763.66-113,803,134.75-62,921,671.28
期末现金及现金等价物余额175,003,515.69146,313,519.58140,918,148.49191,799,611.96
TOP↑